Pharmaceutical Optimization, Molecular Regenerative Mechanisms, and Preclinical Validation of a Topical Mist Formulation Comprising Aloe vera and Centella asiatica Derived Phyto PDRN with Dexpanthenol for Canine and Feline Epidermal Barrier Restoration
Year: 2026
Type: article
Abstract: To fundamentally resolve the inherent limitations of conventional marine fish (salmon and trout)-derived polydeoxyribonucleotide (PDRN)—specifically residual animal protein allergenicity, intense fishy odor leading to behavioral aversion upon oral licking or topical application in companion animals (aversion rate: 47.5%), and marine heavy metal bioaccumulation risks—this study investigated the pharmaceutical optimization, cellular molecular mechanisms, and preclinical efficacy and safety of a topical mist formulation specifically designed for companion animals (canine and feline). The formulation combines highly purified Phyto-PDRN derived from Aloe vera adventitious roots and Centella asiatica (Cica-PDRN; Sodium DNA, 50–1,500 bp) with dexpanthenol (1.0–1.5%), a pivotal epidermal barrier-repair agent, classified as an animal quasi-drug external topical liquid. Unlike human skin, companion animals possess a fragile stratum corneum composed of merely 3–5 cell layers and maintain a neutral to weakly alkaline epidermal surface pH (canine pH 6.2–7.5; feline pH 6.0–7.2). Accordingly, the final formulation was precisely buffered to pH 6.8–7.2. In an oil-free, water-based aerosol system, the severe nozzle-clogging issue associated with poorly soluble ceramide NP (0.05%) was completely resolved via a liquid nano-solubilization premix technology. Regarding antimicrobial preservation, six harmful synthetic preservatives (including parabens and phenoxyethanol) were entirely excluded; instead, an EWG Grade 1 natural multi-preservative booster system consisting of 1,2-hexanediol (1.0%), sodium phytate (0.05%), and ethylhexylglycerin (0.05%) was established, satisfying USP <51> antimicrobial effectiveness criteria and validating a 24-month shelf-life stability (via 6-month accelerated testing at 40°C/75% RH). In vitro bioactivity evaluations demonstrated that the Aloe and Centella PDRN complex exhibited an outstanding DPPH free radical scavenging activity of 96.0%. In human epidermal keratinocytes (HaCaT) and dermal fibroblasts (HDF), the complex markedly upregulated the gene expressions of antioxidant enzyme SOD1 (135.2%), epidermal barrier structural proteins filaggrin (FLG, 128.4%) and loricrin (LOR, 132.8%), and type I collagen (COL1A1, 142.1%), while potently suppressing matrix metalloproteinase-1 (MMP-1) expression to 48.3%. In particular, selective purinergic adenosine A2A receptor (A2AR) activation accelerated fibroblast proliferation by 215.4% (which was abrogated to 112.1% by the selective A2AR antagonist ZM241385, verifying the specific molecular mechanism) and promoted 94.8% scratch wound closure within 24 h. In cellular and animal preclinical models, the formulation protected feline renal epithelial cells (CRFK) against severe oxidative cytopathy, restoring cell viability to 94.1% and decreasing TUNEL-positive apoptotic cells to 8.2%. In BALB/c mice with full-thickness cutaneous excision wounds, the mist complex induced 96.8% re-epithelialization on day 14 alongside robust neo-capillary CD31 angiogenesis and dense collagen remodeling. Moreover, the formulation demonstrated zero mucosal ocular irritation in the chorioallantoic membrane (HET-CAM score 0.0) and achieved exceptional palatability and acceptance rates (90.0–93.3%) in dogs and cats. Consequently, this study successfully establishes the scientific foundation for an oral-safe, 100% vegan animal quasi-drug mist formulation and validates its commercialization and contract development and manufacturing organization (CDMO) viability.
Institution: Seoul National University
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7236470099
